Vivo Bio Tech Ltd

NSE: VIVOBIOT · BSE: 511509 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹14.00
Market cap: ₹22.58 Cr
Revenue (annual): ₹53.33 Cr
Net profit (annual): ₹-1.71 Cr
P/E (TTM): -7.9×Sector 47.4×
Promoter holding: 30.62%-4.81% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Financial Results 4 Board Meeting Date 3 Annual General Meeting 3 Promoter Selling 2 Management Change 2 Capital Structure Change 2 Promoter Selling (Off-Market) 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

13 Jul 2026 19:41 IST BSE

Financial Results

Vivo Bio Tech Q1 FY27 Results: Net Profit ₹0.2 Cr, Down 84.6% YoY

Vivo Bio Tech Ltd reported revenue from operations of ₹14.3 Cr (+14.4% YoY) and net profit of ₹0.2 Cr (-84.6% YoY) for Q1 FY27.

Key figure: Net profit ₹0.2 Cr · -84.6% YoY

Open full results → Read the filing ↗

30 May 2026 19:50 IST BSE

Financial Results

Vivo Bio Tech Q4 FY26 Results: Net Loss of ₹5.2 Cr

Vivo Bio Tech Ltd reported revenue from operations of ₹14.2 Cr (+15.4% YoY) and a net loss of ₹5.2 Cr for Q4 FY26.

Key figure: Net loss ₹5.2 Cr

Open full results → Read the filing ↗

30 May 2026 19:49 IST BSE

Financial Results

Vivo Bio Tech Financial Results

Vivo Bio Tech approved its FY26 audited financial results and the re-appointment of Mr. Kalyan Ram Mangipudi as Whole-time Director. The company also appointed a consultant for an upcoming merger scheme.

Read the filing ↗

3 Apr 2026 17:59 IST BSE

Financial Results

Vivo Bio Tech Q3 FY26 Results: Net Profit ₹1.2 Cr, Up 50.0% YoY

Vivo Bio Tech Ltd reported net profit of ₹1.2 Cr (+50.0% YoY) for Q3 FY26.

Key figure: Net profit ₹1.2 Cr · +50.0% YoY

Open full results → Read the filing ↗